Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Aclaris Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- −1 vs. Q2 2021
- Shares held
- 56.8M
- +817.7K (+1.5%) vs. Q2 2021
- Total value
- $1.02B
- +$39.4M (+4.0%) vs. Q2 2021
- New holders
- 21
- 51 more added
- Sold out
- 22
- 36 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 512,875 | $9.23M | 0.11% | +258,531+101.6% | Added |
| Woodline Partners LP | 594,768 | $10.7M | 0.18% | +594,768 | New |
| Aisling Capital Management LP | 634,455 | $11.4M | 2.28% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 651,783 | $11.7M | 0.13% | +289,783+80.1% | Added |
| Perceptive Advisors LLC | 781,236 | $14.1M | 0.20% | −68,764−8.1% | Reduced |
| Samsara BioCapital, LLC | 794,171 | $14.3M | 2.37% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 795,826 | $14.3M | 0.00% | +77,069+10.7% | Added |
| Vivo Capital, LLC | 940,754 | $16.9M | 0.76% | −433,525−31.5% | Reduced |
| State Street Corp | 1,058,164 | $19.0M | 0.00% | −12,050−1.1% | Reduced |
| Citadel Advisors LLC | 1,063,617 | $19.1M | 0.02% | −163,776−13.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,075,366 | $19.4M | 0.04% | −924,634−46.2% | Reduced |
| Foresite Capital Management V, LLC | 1,258,243 | $22.6M | 7.04% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 1,306,460 | $23.5M | 5.95% | −195,000−13.0% | Reduced |
| BVF Inc | 1,373,044 | $24.7M | 0.96% | +373,044+37.3% | Added |
| Cormorant Asset Management, LP | 1,500,000 | $27.0M | 1.10% | −500,000−25.0% | Reduced |
| FMR LLC | 1,583,089 | $28.5M | 0.00% | −108,885−6.4% | Reduced |
| Foresite Capital Management III, LLC | 1,954,904 | $35.2M | 48.80% | 00.0% | Unchanged |
| Holocene Advisors, LP | 1,955,605 | $35.2M | 0.20% | +557,233+39.8% | Added |
| Renaissance Technologies LLC | 2,020,878 | $36.4M | 0.05% | −411,000−16.9% | Reduced |
| Commodore Capital LP | 2,190,291 | $39.4M | 10.39% | +521,304+31.2% | Added |
| Vanguard Group Inc | 2,678,940 | $48.2M | 0.00% | +112,169+4.4% | Added |
| Foresite Capital Management IV, LLC | 3,399,034 | $61.2M | 9.01% | 00.0% | Unchanged |
| BlackRock Inc. | 3,788,417 | $68.2M | 0.00% | +549,368+17.0% | Added |
| Rock Springs Capital Management LP | 3,803,232 | $68.5M | 1.44% | +40,920+1.1% | Added |
| VR Adviser, LLC | 4,563,962 | $82.2M | 10.55% | 00.0% | Unchanged |
| Wellington Management Group LLP | 5,420,453 | $97.6M | 0.02% | +722,704+15.4% | Added |
| Logos Global Management LP | 0 | $0 | 0.00% | −675,000−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −135,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −114,835−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Jefferies Group LLC | 0 | $0 | 0.00% | −40,063−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −37,334−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −34,739−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −28,975−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −24,532−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −24,061−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −19,174−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −13,658−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −13,555−100.0% | Sold out |
| Twin Securities, Inc. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,264−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −3,195−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −2,588−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,378−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −749−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |